• 3178 Citations
  • 20 h-Index
19992020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

Dr Sue Heatley’s current research is focused on understanding the genetic causes of Acute Lymphoblastic Leukaemia (ALL) in both adults and children. Rapid and accurate identification of these alterations at diagnosis will provide the opportunity for these patients to be treated with currently available targeted therapies. This is likely to lead to immediate improvements in response and long-term outcomes in this group of high risk ALL patients. Her fellowship will investigate single cell genomics in adolescents with high risk B-ALL to determine the clonal evolution of the disease. 

Dr Heatley coordinates a diverse range of projects encompassing ALL research and genomic techniques currently underway in the laboratory. This role also involves the preparation of manuscripts for publication, fellowship applications and research grants, and the supervision of post-graduate students.

Education/Academic qualification

PhD

Masters

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 3178 Citations
  • 20 h-Index
  • 36 Article
  • 3 Letter
  • 1 Short survey
  • 1 Review article

The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL

Tavakoli Shirazi, P., Eadie, L., Heatley, S., Hughes, T., Yeung, D. & White, D., 18 Feb 2020, In : British Journal of Cancer. 122, 4, p. 455-464 10 p.

Research output: Contribution to journalReview article

High Risk Genomic Alterations Identified at the Time of Diagnosis Are Strongly Associated with MRD and Subsequent Poor Outcomes in AYA ALL Patients Treated on a Pediatric Inspired Chemotherapy Regimen

Yeung, D. T., Greenwood, M., Rhen, J., Heatley, S. L., McClure, B., Eadie, L. N., Breen, J., Schutz, C. S., Trahair, T. N., Wei, A. H., Dalla-Pozza, L., Sutton, R., Bradstock, K. F., Osborn, M. P. & White, D. L., 13 Nov 2019, In : Blood. 134, Supplement_1, p. 3949-3949 1 p.

Research output: Contribution to journalArticle

Activating killer-cell immunoglobulin-like receptor haplotype influences clinical outcome following HLA-matched sibling haematopoietic stem cell transplantation

Heatley, S., Mullighan, C. G., Doherty, K., Danner, S., O'Connor, G. M., Hahn, U., Szer, J., Schwarer, A., Bradstock, K., Sullivan, L. C., Bardy, P. G. & Brooks, A. G., Aug 2018, In : HLA. 92, 2, p. 74-82 9 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression

McClure, B., Heatley, S., Kok, C., Sadras, T., An, J., Hughes, T., Lock, R. B., Yeung, D., Sutton, R. & White, D., 1 Apr 2018, In : British Journal of Cancer. 118, 7, p. 1000-1004 5 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)